Bone Metastases Clinical Trials 2023

What are the top hospitals conducting bone metastases research?

When it comes to advancing treatment options for patients with bone metastases, several hospitals are leading the charge. In Houston, M D Anderson Cancer Center takes center stage with an impressive 16 active trials focused on this condition and a total of 23 completed trials since their first recorded study in 2004. Not far behind is Memorial Sloan Kettering Cancer Center in New york, where eight ongoing bone metastases trials contribute to a remarkable tally of 64 all-time completed studies since their pioneering trial in 2003.

Meanwhile, at Dana-Farber Cancer Institute in Boston, researchers are currently conducting seven active clinical trials targeting bone metastases while having achieved significant milestones through their involvement in 34 previous investigations dating back to as early as1999. Further west, Washington University School of Medicine based in Saint Louis dedicates itself to combatting this condition with six ongoing clinical trials and a respectable history encompassing fifteen previously conducted studies since initiating their inaugural trial dedicated solely toward understanding bone metastases backin2008.

Additionally adding itself to this list is The University of Texas MD Anderson Cancer Center located within Houston; they presently participate actively within four comparable research initiatives concerning treating such cases directly contributing towards twelve additional experiments regarding concurrent circumstances originating from just ten years ago until2011.

These esteemed medical institutions serve as beacons of hope for those living with bone metastases and exemplify the tireless efforts being made nationwide to enhance patient outcomes. By pushing the boundaries of scientific knowledge through these groundbreaking clinical trials, they bring us one step closer to more effective treatments that can alleviate suffering and improve quality of life for individuals battling this challenging condition.

Which are the best cities for bone metastases clinical trials?

When it comes to bone metastases clinical trials, several cities have emerged as leaders in research and development. Houston, Texas leads the pack with 35 active trials. New york, New York follows closely behind with 23 ongoing studies, while Boston, Massachusetts and Los Angeles, California both have 22 and 17 active trials respectively. Atlanta, Georgia also joins the list with 17 active trials dedicated to exploring various treatment options. These cities offer individuals affected by bone metastases access to groundbreaking clinical trials that pave the way for advancements in care and provide hope for improved outcomes.

Which are the top treatments for bone metastases being explored in clinical trials?

In the realm of bone metastases, clinical trials are exploring a range of potential treatments that hold promise for patients. Leading the charge is stereotactic radiosurgery, currently being tested in seven active trials and boasting 21 all-time trials dedicated to bone metastases since its introduction in 2004. Another contender gaining traction is abemaciclib, with three ongoing trials and an impressive track record of 12 all-time studies focused on this condition since 2014. Additionally, EMB-01 is showing potential with two active trials and two all-time bone metastases trials since its listing in 2018. Lastly, pembrolizumab demonstrates promise too as it participates in two ongoing clinical trials while accumulating substantial experience with a total of 29 all-time bone metastases studies since first listed in 2015. These endeavors bring hope for improved treatment options to those affected by bone metastases worldwide

What are the most recent clinical trials for bone metastases?

Recent clinical trials offer hope for patients dealing with bone metastases, a challenging condition that arises when cancer spreads to the bones. One such trial focuses on the potential benefits of cemiplimab treatment specifically tailored for bone metastases. Another study investigates the combined approach of stereotactic body radiation therapy (SBRT) and androgen deprivation therapy (ADT), aiming to establish a new standard of care for this condition. Additionally, there is ongoing research into diagnostic techniques like 89Zr panitumumab PET/CT, which can aid in accurately identifying and assessing bone metastases. These innovative approaches demonstrate the dedication of researchers towards finding effective solutions for individuals affected by bone metastases.

What bone metastases clinical trials were recently completed?

Recent clinical trials have made significant progress in the field of bone metastases, aiming to improve treatment options for patients. One such trial, sponsored by the University of Utah and completed in June 2022, focused on MRI Brain and Cervical Spine. Mirati Therapeutics Inc.'s MRTX849 trial was also successfully concluded in August 2021. Additionally, I-Mab Biopharma Co. Ltd.'s TJ210001 trial reached completion in December 2020. These trials highlight the commitment of researchers to advance our understanding and management of bone metastases, offering hope for patients dealing with this challenging condition